Drug – bio-affecting and body treating compositions – Lymphokine
Patent
1990-09-05
1993-08-31
Lee, Lester L.
Drug, bio-affecting and body treating compositions
Lymphokine
530300, 530350, 530403, 530405, 435 693, 435 697, 536 2372, 424 92, C07K 300, C07K 1300, C07K 1500, A61K 3702
Patent
active
052410536
ABSTRACT:
Disclosed are (1) a fused protein comprising heat-labile enterotoxin B subunit and a protein heterologous to heat-labile enterotoxin, (2) a recombinant DNA containing a nucleotide sequence coding for the above fused protein, (3) a transformant harboring the above recombinant DNA, (4) a method for producing the fused protein which comprises cultivating the above transformant, producing and accumulating the above fused protein in a culture, and collecting the fused protein, and (5) a method for purifying a fused protein comprising a herpes simplex virus surface antigen and heat-labile enterotoxin B subunit, which comprises cultivating a transformant harboring a recombinant DNA containing a nucleotide sequence coding for the fused protein, producing an accumulating the fused protein in a culture, collecting the fused protein and subjecting the collected fused protein to purification processes comprising cationic exchange chromatography and gel permeation chromatography.
REFERENCES:
patent: 4285931 (1981-08-01), Limjuco et al.
patent: 4751180 (1988-06-01), Cousens
patent: 4761372 (1988-08-01), Maas et al.
patent: 4837151 (1989-06-01), Stocker
patent: 4892827 (1990-01-01), Pastan et al.
Clements, Biological Abstracts, 90 (2), 1990, Ab. No. 15780 Schodel et al., Chemical Abstracts, 113, 1990 Ab. No. 38498h, p. 425.
Infection And Immunity, 57:1347-1350 (1989).
Abstracts of Annual Meeting of the American Society for Microbiology, p. 16, abstract No. S-6 (1988).
Journal of Bacteriology, 169, 5201-5208 (1987).
Yamamoto, et al., Molecular Organization of Heat-Labile Enterotoxin Genes Originating in Escherichia coli of Human Origin and Construction of Heat-Labile Toxoid-Producing Strains, Journal of Bacteriology, vol. 148, No. 3, pp. 983-987 (1981).
Yamamoto, et al., Release of Heat-Labile Enterotoxin Subunits by Escherichia coli, Journal of Bacteriology, vol. 150, No. 3, pp. 1482-1484 (1982).
Berman, et al., Protection for Genital Herpes Simplex Virus Type 2 Infection by Vaccination with Cloned Type 1 Glycoprotein D, Science, vol. 227, pp. 1409-1492 (1985).
Nozaki, et al., Expression of herpe simplex virus glycoprotein B gene in yeast, Virus Research, vol. 4, pp. 107-113 (1985).
Kino, et al., Immunogenicity of herpes simplex virus glycoprotein gB-1-related protein produced in yeast, Vaccine, vol. 7, pp. 155-160 (1989).
Fujisawa Yukio
Hinuma Shuji
Mayumi Aki
Yamamoto Tatsuo
Conlin David G.
Davenport A. M.
Eisenstein Ronlad I.
Lee Lester L.
Takeda Chemical Industries Ltd.
LandOfFree
Fused proteins comprising glycoprotein gD of HSV-1 and LTB does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused proteins comprising glycoprotein gD of HSV-1 and LTB, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused proteins comprising glycoprotein gD of HSV-1 and LTB will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2298402